Promotional Claim Checker
Before a drug ad goes out, reviewers check every claim against the drug's FDA label. This tool does a first pass: it marks claims that go beyond the label and shows the FDA letters that objected to the same kind of claim.
Pick a drug and paste its promotional copy. Each claim FDA would likely object to comes back with the label text it should be checked against and the OPDP letters that objected to the same kind of claim, quoted and linked.
- OPDP letters to cite: 145
- Label sections read: 6
- Free checks a day: 3
About this checker
What it flags
- Beyond the approved use or population
- Efficacy overstated against the label
- Risk minimized or fair balance missing
- Unsupported superiority or comparison
- โSafeโ, โprovenโ or โno side effectsโ language
- Material facts omitted
The label sections it reads are the Boxed Warning, Indications and Usage, Contraindications, Warnings and Precautions, Adverse Reactions and Clinical Studies. The precedents come from the letters in the OPDP letter search.
How it works
The copy, the label sections and the key sentences of every OPDP untitled and warning letter go to the model Arcaโs Research AI uses, which proposes flags with quotes. Before anything is shown, each quote is looked up in its source by its words, ignoring spacing, punctuation and case. The text you see is cut from the source, not the modelโs retelling of it.
Frequently asked questions
- Is my copy stored?
- No. It is sent to the model to answer this one check and returned to your browser. The server logs only the drug, the length of the copy and how many claims were flagged. A Word file is read in your browser; only its text is sent.
- Can I trust a flag?
- Every quote on a flag has been found word for word in the source it names: the claim in your copy, the label passage in the drugโs current label, the letter sentence in that OPDP letter. Flags whose quotes could not be found are dropped and counted. Whether the claim is really a problem is a reviewerโs judgment.
- Does no flag mean the piece is fine?
- No. This is a first-pass screen, not MLR approval or legal advice. It reads the words, not the images, layout, audio or how prominently risk is shown, and it can miss problems a reviewer would catch.
- Which label is used?
- The newest prescribing label openFDA has for the drugโs brand applications (NDA or BLA), the same text DailyMed publishes. Its version and effective date are shown with the results.
- How many checks can I run?
- 3 a day without an account, 25 a day signed in. Each check is a long model read of the label and the letters.